US Stock MarketDetailed Quotes

RAPP Rapport Therapeutics

Watchlist
  • 24.620
  • +0.090+0.37%
Close Nov 1 16:00 ET
  • 24.620
  • 0.0000.00%
Post 16:20 ET
900.51MMarket Cap-14289P/E (TTM)

Rapport Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Oct 31, 2024

Based on 3 analysts giving stock ratings to Rapport Therapeutics in the past 3 months

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

Updated: Oct 31, 2024

The average Rapport Therapeutics stock price target is 38.50 with a max estimate of 42.00 and a min estimate of 35.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Oct 31, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

Updated: Oct 31, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data